EDAP TMS Reports Third Quarter 2017 Results EDAP's HIFU patient treatment revenues grew 29% compared to third quarter 2016. EDAP received FDA clearance for its Ablatherm Fusion ® late in the quarter. EDAP's cash position remains strong at US $21.3 million on September 30, 2017 LYON, France ,
Contact: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 72 bconfort@edap-tms.com Investors: Rich Cockrell CG CAPITAL 877.889.1972 rich@cg.capital Conference Call to Review Results to be Held Thursday, November 16, 2017 LYON, France , November 01, 2017 - EDAP TMS SA
EDAP to Market Echotherapy for ablation of breast fibroadenomas and benign thyroid nodules LYON, France , October 9, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the signature of an Agreement with French HIFU Company Theraclion, to exclusively
LYON, France , October 4, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced FDA approval of its Ablatherm-Fusion device enabling a more precise method for targeting of diagnosed areas within the prostate. Marc Oczachowski , Chief Executive Officer of
University of Chicago Medicine - Dr. A. Shalhav, Chair of Urology Surgery and Director of Robotic Surgery Vituro Health LLC - Dr. S. Scionti , Medical Director and Director of The Scionti Prostate Center in Sarasota, FL LYON, France , September 19, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global
510(k) Includes New Clinical Data to Support EDAP's File LYON, France , September 11, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company submitted a new 510(k) application for its Focal One device, including an updated clinical section
Dr. S. Scionti , Medical Director of Vituro and most experienced HIFU urologist in the U.S. to start treating with Ablatherm in September LYON, France , August 31, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company signed a partnership
LYON, France , August 24, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski , Chief Executive Officer, will present at the 19 th Annual Rodman & Renshaw Global Investment Conference to be held September 10-12, 2017
EDAP-TMS Reports Record Second Quarter and First Half 2017 Results Revenue increased 13.7% to a record €9.3 million for the second quarter of 2017 compared to €8.2 million in 2016 HIFU revenue grew 25% when compared to first quarter of 2017 Ablatherm Fusion 510(k) submission completed C-Code
